Posterior Tibia Nerve Neuroprolotherapy for Dysmenorrhea

Launched by TAICHUNG ARMED FORCES GENERAL HOSPITAL · Mar 2, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called posterior tibia nerve neuroprolotherapy to see if it can help reduce the pain associated with dysmenorrhea, which is commonly known as menstrual pain. The main goal is to find out if this treatment can improve pain levels as measured on a scale where patients rate their pain. Women between the ages of 18 and 50 who have regular menstrual cycles and experience pain during their periods may be eligible to participate.

If you join the study, you will be randomly placed in one of two groups. One group will receive neuroprolotherapy for the first two menstrual cycles and then take acetaminophen (a common pain reliever) for the next two cycles. The other group will start with acetaminophen for the first two cycles and then receive neuroprolotherapy. The study is currently looking for participants, and it’s important to note that women with certain conditions, like pregnancy or serious health issues, cannot take part. This trial aims to provide new insights into managing menstrual pain and could be a valuable option for women suffering from dysmenorrhea.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • women aged 18-50 who experience normal menstrual cycles accompanied by menstrual pain
• Exclusion Criteria:
• • Malignant tumors requiring treatment.
• • Pregnant
• • Those who have other acute and chronic pain and are receiving relevant drug treatment.
• • Those who are allergic to acetaminophen or have contraindications.
• • Those who use hormonal contraceptives at the same time.
• • Those with coagulation disorders or taking anticoagulant drugs.